Trial Profile
Morning Homed Blood Pressure Trial in elderly hypertensive patients with olmesartan medoxomil compared to azilsartan
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Apr 2018
Price :
$35
*
At a glance
- Drugs Olmesartan medoxomil (Primary) ; Azilsartan
- Indications Essential hypertension
- Focus Therapeutic Use
- Acronyms MHBP
- Sponsors Daiichi Sankyo Company
- 28 Mar 2018 Status changed from active, no longer recruiting to completed.
- 06 Jan 2017 Status changed from recruiting to active, no longer recruiting.
- 18 May 2016 New trial record